Pharmaceutical industry representatives in Washington are scrambling to measure the damage Robert F. Kennedy Jr. might inflict on the FDA.

Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...

Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Zevra Therapeutics (ZVRA – Research Report). The associated ...

The FDA spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay ...

Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...

President-elect Donald Trump has picked a prominent vaccine skeptic to lead the nation's sprawling public health apparatus.

Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported financial results for its third quarter ended ...

SOL-1 expected to be fully randomized by YE 2024 with topline data expected in Q4 2025 Cash balance of $427.2M as of September 30, 2024, expected to fund operations into 2028 Ocular to host a Q3 2024 ...

responses to the FDA's findings from Module 1 were also submitted, which the company believes are minor findings. In addition, the finalization of Module 3 is ongoing. The US FDA has agreed to a ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

AstraZeneca's China president Leon Wang, who was detained last month by Chinese authorities, is in touch with a lawyer but ...